Unimpaired energy metabolism in experimental neuropathy induced by p-bromophenylacetylurea

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The contribution of defective energy metabolism to the induction of neuronal pathology by p-bromophenylacetylurea (BPAU) was examined in several ways. It was found that a saturated aqueous solution of BPAU had no effect on the activity of crystalline glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or phosphofructokinase (PFK). In rats with total hindlimb paralysis from treatment with BPAU (400 mg/kg), the endogenous GAPDH and PFK of sciatic nerve showed normal activity. Endogenous enolase and nerve-specific enolase activities were likewise unaffected. Consequently, it appeared improbable that BPAU neuropathy involves impaired glycolysis. This conclusion was supported by the failure to prevent hindlimb weakness by feeding pyruvate, a substrate for the Krebs cycle. To test for interference with glycolysis at other steps, or for an impairment in oxidative phosphorylation, adenosine triphosphate (ATP) and creatine phosphate were measured. The amounts of high energy phosphates in nerves of paralyzed animals were found to be the same as in nerves of untreated and vehicle-treated controls. A similar observation was made in nerves regenerating from a crush injury. To test turnover, ATP and creatine phosphate were measured in nerves exposed to an N2 atmosphere in vitro. Since the high energy phosphates disappeared at the same rates in all groups, it was concluded that BPAU neuropathy does not alter energy utilization. In our view, BPAU neuropathy arises by a mechanism that does not depend on altered energy metabolism.

Original languageEnglish (US)
Pages (from-to)725-732
Number of pages8
JournalMuscle and Nerve
Volume7
Issue number9
StatePublished - 1984

Fingerprint

Phosphofructokinases
Glyceraldehyde-3-Phosphate Dehydrogenases
Phosphocreatine
Adenine Nucleotides
Phosphopyruvate Hydratase
Glycolysis
Hindlimb
Energy Metabolism
Adenosine Triphosphate
Phosphates
Citric Acid Cycle
Oxidative Phosphorylation
Sciatic Nerve
Pyruvic Acid
Atmosphere
Paralysis
Pathology
4-bromophenylacetylurea
In Vitro Techniques
Crush Injuries

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Unimpaired energy metabolism in experimental neuropathy induced by p-bromophenylacetylurea. / Brimijoin, William Stephen; Mintz, K. P.

In: Muscle and Nerve, Vol. 7, No. 9, 1984, p. 725-732.

Research output: Contribution to journalArticle

@article{47f8f904cd3340f989b7fd1164acb1b3,
title = "Unimpaired energy metabolism in experimental neuropathy induced by p-bromophenylacetylurea",
abstract = "The contribution of defective energy metabolism to the induction of neuronal pathology by p-bromophenylacetylurea (BPAU) was examined in several ways. It was found that a saturated aqueous solution of BPAU had no effect on the activity of crystalline glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or phosphofructokinase (PFK). In rats with total hindlimb paralysis from treatment with BPAU (400 mg/kg), the endogenous GAPDH and PFK of sciatic nerve showed normal activity. Endogenous enolase and nerve-specific enolase activities were likewise unaffected. Consequently, it appeared improbable that BPAU neuropathy involves impaired glycolysis. This conclusion was supported by the failure to prevent hindlimb weakness by feeding pyruvate, a substrate for the Krebs cycle. To test for interference with glycolysis at other steps, or for an impairment in oxidative phosphorylation, adenosine triphosphate (ATP) and creatine phosphate were measured. The amounts of high energy phosphates in nerves of paralyzed animals were found to be the same as in nerves of untreated and vehicle-treated controls. A similar observation was made in nerves regenerating from a crush injury. To test turnover, ATP and creatine phosphate were measured in nerves exposed to an N2 atmosphere in vitro. Since the high energy phosphates disappeared at the same rates in all groups, it was concluded that BPAU neuropathy does not alter energy utilization. In our view, BPAU neuropathy arises by a mechanism that does not depend on altered energy metabolism.",
author = "Brimijoin, {William Stephen} and Mintz, {K. P.}",
year = "1984",
language = "English (US)",
volume = "7",
pages = "725--732",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Unimpaired energy metabolism in experimental neuropathy induced by p-bromophenylacetylurea

AU - Brimijoin, William Stephen

AU - Mintz, K. P.

PY - 1984

Y1 - 1984

N2 - The contribution of defective energy metabolism to the induction of neuronal pathology by p-bromophenylacetylurea (BPAU) was examined in several ways. It was found that a saturated aqueous solution of BPAU had no effect on the activity of crystalline glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or phosphofructokinase (PFK). In rats with total hindlimb paralysis from treatment with BPAU (400 mg/kg), the endogenous GAPDH and PFK of sciatic nerve showed normal activity. Endogenous enolase and nerve-specific enolase activities were likewise unaffected. Consequently, it appeared improbable that BPAU neuropathy involves impaired glycolysis. This conclusion was supported by the failure to prevent hindlimb weakness by feeding pyruvate, a substrate for the Krebs cycle. To test for interference with glycolysis at other steps, or for an impairment in oxidative phosphorylation, adenosine triphosphate (ATP) and creatine phosphate were measured. The amounts of high energy phosphates in nerves of paralyzed animals were found to be the same as in nerves of untreated and vehicle-treated controls. A similar observation was made in nerves regenerating from a crush injury. To test turnover, ATP and creatine phosphate were measured in nerves exposed to an N2 atmosphere in vitro. Since the high energy phosphates disappeared at the same rates in all groups, it was concluded that BPAU neuropathy does not alter energy utilization. In our view, BPAU neuropathy arises by a mechanism that does not depend on altered energy metabolism.

AB - The contribution of defective energy metabolism to the induction of neuronal pathology by p-bromophenylacetylurea (BPAU) was examined in several ways. It was found that a saturated aqueous solution of BPAU had no effect on the activity of crystalline glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or phosphofructokinase (PFK). In rats with total hindlimb paralysis from treatment with BPAU (400 mg/kg), the endogenous GAPDH and PFK of sciatic nerve showed normal activity. Endogenous enolase and nerve-specific enolase activities were likewise unaffected. Consequently, it appeared improbable that BPAU neuropathy involves impaired glycolysis. This conclusion was supported by the failure to prevent hindlimb weakness by feeding pyruvate, a substrate for the Krebs cycle. To test for interference with glycolysis at other steps, or for an impairment in oxidative phosphorylation, adenosine triphosphate (ATP) and creatine phosphate were measured. The amounts of high energy phosphates in nerves of paralyzed animals were found to be the same as in nerves of untreated and vehicle-treated controls. A similar observation was made in nerves regenerating from a crush injury. To test turnover, ATP and creatine phosphate were measured in nerves exposed to an N2 atmosphere in vitro. Since the high energy phosphates disappeared at the same rates in all groups, it was concluded that BPAU neuropathy does not alter energy utilization. In our view, BPAU neuropathy arises by a mechanism that does not depend on altered energy metabolism.

UR - http://www.scopus.com/inward/record.url?scp=0021677312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021677312&partnerID=8YFLogxK

M3 - Article

C2 - 6100457

AN - SCOPUS:0021677312

VL - 7

SP - 725

EP - 732

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 9

ER -